|
Volumn 19, Issue 2, 2006, Pages 259-262
|
Preface
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLT3 LIGAND;
IMATINIB;
MIXED LINEAGE LEUKEMIA PROTEIN;
RETINOIC ACID;
TUMOR SUPPRESSOR PROTEIN;
ACUTE GRANULOCYTIC LEUKEMIA;
CHRONIC MYELOID LEUKEMIA;
CLUSTER ANALYSIS;
CYTOGENETICS;
EDITORIAL;
EUROPE;
GENE EXPRESSION;
GENE EXPRESSION PROFILING;
GENE MUTATION;
HUMAN;
KARYOTYPE;
MEDICAL DECISION MAKING;
PATIENT CARE;
PRIORITY JOURNAL;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
RISK ASSESSMENT;
TANDEM REPEAT;
TREATMENT OUTCOME;
UNITED STATES;
ALGORITHM;
ARTICLE;
GENETICS;
HISTORY;
METABOLISM;
METHODOLOGY;
MORTALITY;
ALGORITHMS;
CYTOGENETICS;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
PROGNOSIS;
|
EID: 33644499852
PISSN: 15216926
EISSN: None
Source Type: Journal
DOI: 10.1016/j.beha.2005.11.009 Document Type: Editorial |
Times cited : (3)
|
References (4)
|